Divis Laboratories Ltd | DIVI - PE Price to Earnings

Stock Price
6,467.50
Daily Change
106.00 1.67%
Monthly
8.75%
Yearly
7.32%
Q2 Forecast
6,221.55

Divis Laboratories Ltd reported 66.5 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Aurobindo Pharma 19.2 0.95 Dec/2025
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 66.5 5.69 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 26.59 2.03 Dec/2025
Lupin 17.5 2.33 Dec/2025
Moderna 27.22 14.51 Jun/2023
Organon & Co 3.75 0.87 Dec/2025
Revvity 49.87 16.58 Dec/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 10.4 11.84 Sep/2025